Sp163
INCORPORATING A GI EXPERT DIETITIAN IN A GI ACADEMIC CENTER (CASE STUDY/DEMO)
Date
May 18, 2024
Presenters
Michigan Medicine
Tracks
Related Products
Irritable Bowel Syndrome Clinical
TREATMENT WITH THE HISTAMINE 1 RECEPTOR ANTAGONIST EBASTINE FOR NON-CONSTIPATED IRRITABLE BOWEL SYNDROME: A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED TRIAL
DOES THE MEDITERRANEAN DIET HAVE SIMILAR EFFICACY AS A LOW FODMAP DIET IN IRRITABLE BOWEL SYNDROME? RESULTS FROM A PILOT RANDOMIZED CONTROLLED TRIAL
INTRODUCTION: A diet low in FODMAPs (LFD) is only effective in 50-60% of patients with irritable bowel syndrome (IBS) and is restrictive, time-consuming, and carries the risk of nutritional deficiencies. Therefore, there is a need for novel dietary therapies for IBS…
IS A SIMPLIFIED LOW FODMAP RESTRICTION PHASE POSSIBLE? RESULTS FROM A MULTI-CENTER, DOUBLE-BLIND, PILOT-FEASIBILITY, RANDOMIZED CONTROLLED TRIAL
INTRODUCTION: The current ‘step-down’ approach to implementing a low FODMAP diet (LFD) in which all 5 FODMAP groups are restricted presents significant practical challenges for patients, A ‘step-up’ approach has been proposed where only 1-2 FODMAP groups are initially restricted and further restric…
